The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Graphite Bio Inc(NASDAQ:GRPH) 
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH102 for the treatment of beta-thalassemia; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH30...
Graphite Bio Number of Twitter Followers
Graphite Bio Days Payable Outstanding ttm (DPO)
Graphite Bio Op Cashflow Per Share ttm
Graphite Bio Free Cashflow Per Share ttm
Graphite Bio Cash Per Share ttm
Graphite Bio P/S ratio ttm
Graphite Bio (GAAP) P/E ratio ttm
Graphite Bio P/B ratio ttm
No extra charts and metrics for this ticker.